 | • レポートコード：GIR-105X14598 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ロフェコキシブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ロフェコキシブの種類別市場規模（経口懸濁液、錠剤型）、用途別市場規模（変形性関節症、関節リウマチ、若年性関節リウマチ、急性痛状態、片頭痛、月経困難症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ロフェコキシブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Chengdu Meinkai Chemical Co. LTD、Wuhan Xinxin Jiali Biotechnology Co. LTD、Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD、Pfizer、Tremeau ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口懸濁液、錠剤型 ・用途別分析2016年-2026年：変形性関節症、関節リウマチ、若年性関節リウマチ、急性痛状態、片頭痛、月経困難症 ・ロフェコキシブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ロフェコキシブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ロフェコキシブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ロフェコキシブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ロフェコキシブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Rofecoxib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Rofecoxib size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Rofecoxib market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Rofecoxib market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral Suspension.
Tablet-Form
Market segment by Application can be divided into
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
The key market players for global Rofecoxib market are listed below:
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Rofecoxib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rofecoxib Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral Suspension.
1.2.3 Tablet-Form
1.3 Market Analysis by Application
1.3.1 Overview: Global Rofecoxib Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Osteoarthritis
1.3.3 Rheumatoid Arthritis
1.3.4 Juvenile Rheumatoid Arthritis
1.3.5 Acute Pain Conditions
1.3.6 Migraine
1.3.7 Dysmenorrhea
1.4 Global Rofecoxib Market Size & Forecast
1.4.1 Global Rofecoxib Sales in Value (2016-2026))
1.4.2 Global Rofecoxib Sales in Volume (2016-2026)
1.4.3 Global Rofecoxib Price by Type (2016-2026) & (USD/MT)
1.5 Global Rofecoxib Production Capacity Analysis
1.5.1 Global Rofecoxib Total Production Capacity (2016-2026)
1.5.2 Global Rofecoxib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Rofecoxib Market Drivers
1.6.2 Rofecoxib Market Restraints
1.6.3 Rofecoxib Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Rofecoxib Product and Services
2.1.4 Merck Rofecoxib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Chengdu Meinkai Chemical Co. LTD
2.2.1 Chengdu Meinkai Chemical Co. LTD Details
2.2.2 Chengdu Meinkai Chemical Co. LTD Major Business
2.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product and Services
2.2.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
2.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Details
2.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Major Business
2.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product and Services
2.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
2.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Details
2.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Major Business
2.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product and Services
2.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Rofecoxib Product and Services
2.5.4 Pfizer Rofecoxib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Tremeau
2.6.1 Tremeau Details
2.6.2 Tremeau Major Business
2.6.3 Tremeau Rofecoxib Product and Services
2.6.4 Tremeau Rofecoxib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Rofecoxib Sales by Manufacturer
3.1 Global Rofecoxib Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Rofecoxib Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Rofecoxib
3.4 Market Concentration Rate
3.4.1 Top 3 Rofecoxib Manufacturer Market Share
3.4.2 Top 6 Rofecoxib Manufacturer Market Share
3.5 Global Rofecoxib Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Rofecoxib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Rofecoxib Market Size by Region
4.1.1 Global Rofecoxib Sales in Volume by Region (2016-2026)
4.1.2 Global Rofecoxib Revenue by Region (2016-2026)
4.2 North America Rofecoxib Revenue (2016-2026)
4.3 Europe Rofecoxib Revenue (2016-2026)
4.4 Asia-Pacific Rofecoxib Revenue (2016-2026)
4.5 South America Rofecoxib Revenue (2016-2026)
4.6 Middle East and Africa Rofecoxib Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Rofecoxib Sales in Volume by Type (2016-2026)
5.2 Global Rofecoxib Revenue by Type (2016-2026)
5.3 Global Rofecoxib Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Rofecoxib Sales in Volume by Application (2016-2026)
6.2 Global Rofecoxib Revenue by Application (2016-2026)
6.3 Global Rofecoxib Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Rofecoxib Sales by Type (2016-2026)
7.2 North America Rofecoxib Sales by Application (2016-2026)
7.3 North America Rofecoxib Market Size by Country
7.3.1 North America Rofecoxib Sales in Volume by Country (2016-2026)
7.3.2 North America Rofecoxib Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Rofecoxib Sales by Type (2016-2026)
8.2 Europe Rofecoxib Sales by Application (2016-2026)
8.3 Europe Rofecoxib Market Size by Country
8.3.1 Europe Rofecoxib Sales in Volume by Country (2016-2026)
8.3.2 Europe Rofecoxib Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Rofecoxib Sales by Type (2016-2026)
9.2 Asia-Pacific Rofecoxib Sales by Application (2016-2026)
9.3 Asia-Pacific Rofecoxib Market Size by Region
9.3.1 Asia-Pacific Rofecoxib Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Rofecoxib Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Rofecoxib Sales by Type (2016-2026)
10.2 South America Rofecoxib Sales by Application (2016-2026)
10.3 South America Rofecoxib Market Size by Country
10.3.1 South America Rofecoxib Sales in Volume by Country (2016-2026)
10.3.2 South America Rofecoxib Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Rofecoxib Sales by Type (2016-2026)
11.2 Middle East & Africa Rofecoxib Sales by Application (2016-2026)
11.3 Middle East & Africa Rofecoxib Market Size by Country
11.3.1 Middle East & Africa Rofecoxib Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Rofecoxib Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Rofecoxib Typical Distributors
12.3 Rofecoxib Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Rofecoxib Revenue by Type, (USD Million), 2021-2026
Table 2. Global Rofecoxib Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Rofecoxib Product and Services
Table 6. Merck Rofecoxib Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Chengdu Meinkai Chemical Co. LTD Basic Information, Manufacturing Base and Competitors
Table 8. Chengdu Meinkai Chemical Co. LTD Major Business
Table 9. Chengdu Meinkai Chemical Co. LTD Rofecoxib Product and Services
Table 10. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Wuhan Xinxin Jiali Biotechnology Co. LTD Basic Information, Manufacturing Base and Competitors
Table 12. Wuhan Xinxin Jiali Biotechnology Co. LTD Major Business
Table 13. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product and Services
Table 14. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Basic Information, Manufacturing Base and Competitors
Table 16. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Major Business
Table 17. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product and Services
Table 18. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Rofecoxib Product and Services
Table 22. Pfizer Rofecoxib Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Tremeau Basic Information, Manufacturing Base and Competitors
Table 24. Tremeau Major Business
Table 25. Tremeau Rofecoxib Product and Services
Table 26. Tremeau Rofecoxib Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Global Rofecoxib Sales by Manufacturer (2019-2021e) & (MT)
Table 28. Global Rofecoxib Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 29. Market Position of Manufacturers in Rofecoxib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 30. Global Rofecoxib Production Capacity by Company, (MT): 2020 VS 2021
Table 31. Head Office and Rofecoxib Production Site of Key Manufacturer
Table 32. Global Rofecoxib Sales by Region (2016-2021e) & (MT)
Table 33. Global Rofecoxib Sales by Region (2021-2026) & (MT)
Table 34. Global Rofecoxib Revenue by Region (2016-2021e) & (USD Million)
Table 35. Global Rofecoxib Revenue by Region (2021-2026) & (USD Million)
Table 36. Global Rofecoxib Sales by Type (2016-2021e) & (MT)
Table 37. Global Rofecoxib Sales by Type (2021-2026) & (MT)
Table 38. Global Rofecoxib Revenue by Type (2016-2021e) & (USD Million)
Table 39. Global Rofecoxib Revenue by Type (2021-2026) & (USD Million)
Table 40. Global Rofecoxib Price by Type (2016-2021e) & (USD/MT)
Table 41. Global Rofecoxib Price by Type (2021-2026) & (USD/MT)
Table 42. Global Rofecoxib Sales by Application (2016-2021e) & (MT)
Table 43. Global Rofecoxib Sales by Application (2021-2026) & (MT)
Table 44. Global Rofecoxib Revenue by Application (2016-2021e) & (USD Million)
Table 45. Global Rofecoxib Revenue by Application (2021-2026) & (USD Million)
Table 46. Global Rofecoxib Price by Application (2016-2021e) & (USD/MT)
Table 47. Global Rofecoxib Price by Application (2021-2026) & (USD/MT)
Table 48. North America Rofecoxib Sales by Country (2016-2021e) & (MT)
Table 49. North America Rofecoxib Sales by Country (2021-2026) & (MT)
Table 50. North America Rofecoxib Revenue by Country (2016-2021e) & (USD Million)
Table 51. North America Rofecoxib Revenue by Country (2021-2026) & (USD Million)
Table 52. North America Rofecoxib Sales by Type (2016-2021e) & (MT)
Table 53. North America Rofecoxib Sales by Type (2021-2026) & (MT)
Table 54. North America Rofecoxib Sales by Application (2016-2021e) & (MT)
Table 55. North America Rofecoxib Sales by Application (2021-2026) & (MT)
Table 56. Europe Rofecoxib Sales by Country (2016-2021e) & (MT)
Table 57. Europe Rofecoxib Sales by Country (2021-2026) & (MT)
Table 58. Europe Rofecoxib Revenue by Country (2016-2021e) & (USD Million)
Table 59. Europe Rofecoxib Revenue by Country (2021-2026) & (USD Million)
Table 60. Europe Rofecoxib Sales by Type (2016-2021e) & (MT)
Table 61. Europe Rofecoxib Sales by Type (2021-2026) & (MT)
Table 62. Europe Rofecoxib Sales by Application (2016-2021e) & (MT)
Table 63. Europe Rofecoxib Sales by Application (2021-2026) & (MT)
Table 64. Asia-Pacific Rofecoxib Sales by Region (2016-2021e) & (MT)
Table 65. Asia-Pacific Rofecoxib Sales by Region (2021-2026) & (MT)
Table 66. Asia-Pacific Rofecoxib Revenue by Region (2016-2021e) & (USD Million)
Table 67. Asia-Pacific Rofecoxib Revenue by Region (2021-2026) & (USD Million)
Table 68. Asia-Pacific Rofecoxib Sales by Type (2016-2021e) & (MT)
Table 69. Asia-Pacific Rofecoxib Sales by Type (2021-2026) & (MT)
Table 70. Asia-Pacific Rofecoxib Sales by Application (2016-2021e) & (MT)
Table 71. Asia-Pacific Rofecoxib Sales by Application (2021-2026) & (MT)
Table 72. South America Rofecoxib Sales by Country (2016-2021e) & (MT)
Table 73. South America Rofecoxib Sales by Country (2021-2026) & (MT)
Table 74. South America Rofecoxib Revenue by Country (2016-2021e) & (USD Million)
Table 75. South America Rofecoxib Revenue by Country (2021-2026) & (USD Million)
Table 76. South America Rofecoxib Sales by Type (2016-2021e) & (MT)
Table 77. South America Rofecoxib Sales by Type (2021-2026) & (MT)
Table 78. South America Rofecoxib Sales by Application (2016-2021e) & (MT)
Table 79. South America Rofecoxib Sales by Application (2021-2026) & (MT)
Table 80. Middle East & Africa Rofecoxib Sales by Country (2016-2021e) & (MT)
Table 81. Middle East & Africa Rofecoxib Sales by Country (2021-2026) & (MT)
Table 82. Middle East & Africa Rofecoxib Revenue by Country (2016-2021e) & (USD Million)
Table 83. Middle East & Africa Rofecoxib Revenue by Country (2021-2026) & (USD Million)
Table 84. Middle East & Africa Rofecoxib Sales by Type (2016-2021e) & (MT)
Table 85. Middle East & Africa Rofecoxib Sales by Type (2021-2026) & (MT)
Table 86. Middle East & Africa Rofecoxib Sales by Application (2016-2021e) & (MT)
Table 87. Middle East & Africa Rofecoxib Sales by Application (2021-2026) & (MT)
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Rofecoxib Typical Distributors
Table 91. Rofecoxib Typical Customers
List of Figures
Figure 1. Rofecoxib Picture
Figure 2. Global Rofecoxib Sales Market Share by Type in 2020
Figure 3. Oral Suspension.
Figure 4. Tablet-Form
Figure 5. Global Rofecoxib Sales Market Share by Application in 2020
Figure 6. Osteoarthritis
Figure 7. Rheumatoid Arthritis
Figure 8. Juvenile Rheumatoid Arthritis
Figure 9. Acute Pain Conditions
Figure 10. Migraine
Figure 11. Dysmenorrhea
Figure 12. Global Rofecoxib Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 13. Global Rofecoxib Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Rofecoxib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Rofecoxib Sales (2016-2026) & (MT)
Figure 34. Global Rofecoxib Production Capacity (2016-2026) & (MT)
Figure 35. Global Rofecoxib Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Rofecoxib Market Drivers
Figure 37. Rofecoxib Market Restraints
Figure 38. Rofecoxib Market Trends
Figure 39. Global Rofecoxib Sales Market Share by Manufacturer in 2020
Figure 40. Global Rofecoxib Revenue Market Share by Manufacturer in 2020
Figure 41. Rofecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Rofecoxib Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Rofecoxib Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Rofecoxib Sales Market Share by Region (2016-2026)
Figure 45. Global Rofecoxib Revenue Market Share by Region (2016-2026)
Figure 46. North America Rofecoxib Revenue (2016-2026) & (USD Million)
Figure 47. Europe Rofecoxib Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Rofecoxib Revenue (2016-2026) & (USD Million)
Figure 49. South America Rofecoxib Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Rofecoxib Revenue (2016-2026) & (USD Million)
Figure 51. Global Rofecoxib Sales Market Share by Type (2016-2026)
Figure 52. Global Rofecoxib Revenue Market Share by Type (2016-2026)
Figure 53. Global Rofecoxib Price by Type (2016-2026) & (USD/MT)
Figure 54. Global Rofecoxib Sales Market Share by Application (2016-2026)
Figure 55. Global Rofecoxib Revenue Market Share by Application (2016-2026)
Figure 56. Global Rofecoxib Price by Application (2016-2026) & (USD/MT)
Figure 57. North America Rofecoxib Sales Market Share by Country (2016-2026)
Figure 58. North America Rofecoxib Revenue Market Share by Country (2016-2026)
Figure 59. North America Rofecoxib Sales Market Share by Type (2016-2026)
Figure 60. North America Rofecoxib Sales Market Share by Application (2016-2026)
Figure 61. Europe Rofecoxib Sales Market Share by Country (2016-2026)
Figure 62. Europe Rofecoxib Revenue Market Share by Country (2016-2026)
Figure 63. Europe Rofecoxib Sales Market Share by Type (2016-2026)
Figure 64. Europe Rofecoxib Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Rofecoxib Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Rofecoxib Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Rofecoxib Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Rofecoxib Sales Market Share by Application (2016-2026)
Figure 69. South America Rofecoxib Sales Market Share by Country (2016-2026)
Figure 70. South America Rofecoxib Revenue Market Share by Country (2016-2026)
Figure 71. South America Rofecoxib Sales Market Share by Type (2016-2026)
Figure 72. South America Rofecoxib Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Rofecoxib Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Rofecoxib Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Rofecoxib Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Rofecoxib Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
エトリコキシブ中間体の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely cyclooxygenase-2 and COX-2. Scope of the Report: This report focuses on the Etoricoxib Intermediate in global market, especially in North America, Europe and Asia…- 世界の関節炎粘液補充療法市場 2021：企業別、地域別、種類・用途別 The Viscosupplementation Treatment for Arthritis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界の乾癬性関節炎治療薬市場 2021：企業別、地域別、種類・用途別 The Psoriatic Arthritis Therapeutics Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- シミジア（セルトリズマブ）医薬品の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Certolizumab pegol is a TNF (tumor necrosis factor) inhibitor that is primarily used to treat Crohns disease. Certolizumab pegol is a monoclonal antibody directed against tumor necrosis factor alpha (TNF-alfa). In 2008, it was approved for rheumatoid arthritis treatment under the brand CIMZIA®. It …
- 変形性関節症の痛みの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Osteoarthritis, the most common type of arthritis, is a leading cause of disability. Scope of the Report: This report focuses on the Osteoarthritis Pain in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market b…